|
1
|
Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility.
|
Cancer Res
|
2005
|
2.08
|
|
2
|
Engineering nanocages with polyglutamate domains for coupling to hydroxyapatite biomaterials and allograft bone.
|
Biomaterials
|
2013
|
1.47
|
|
3
|
Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis.
|
J Biol Chem
|
2008
|
1.40
|
|
4
|
Regulation of the metastatic cell phenotype by sialylated glycans.
|
Cancer Metastasis Rev
|
2012
|
1.32
|
|
5
|
ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function.
|
J Ovarian Res
|
2008
|
1.26
|
|
6
|
The effect of RGD peptides on osseointegration of hydroxyapatite biomaterials.
|
Biomaterials
|
2008
|
1.26
|
|
7
|
Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors.
|
J Biol Chem
|
2002
|
1.25
|
|
8
|
Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function.
|
J Biol Chem
|
2010
|
1.23
|
|
9
|
Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells.
|
J Biol Chem
|
2011
|
1.19
|
|
10
|
Identification of a HoxA10 activation domain necessary for transcription of the gene encoding beta3 integrin during myeloid differentiation.
|
J Biol Chem
|
2007
|
1.18
|
|
11
|
A protein kinase C/Ras/ERK signaling pathway activates myeloid fibronectin receptors by altering beta1 integrin sialylation.
|
J Biol Chem
|
2005
|
1.15
|
|
12
|
The effect of adsorbed serum proteins, RGD and proteoglycan-binding peptides on the adhesion of mesenchymal stem cells to hydroxyapatite.
|
Biomaterials
|
2006
|
1.15
|
|
13
|
ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines.
|
Cancer Res
|
2013
|
1.15
|
|
14
|
Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.
|
Clin Cancer Res
|
2013
|
1.13
|
|
15
|
Increasing the pore sizes of bone-mimetic electrospun scaffolds comprised of polycaprolactone, collagen I and hydroxyapatite to enhance cell infiltration.
|
Biomaterials
|
2011
|
1.11
|
|
16
|
The effect of collagen I mimetic peptides on mesenchymal stem cell adhesion and differentiation, and on bone formation at hydroxyapatite surfaces.
|
Biomaterials
|
2009
|
1.10
|
|
17
|
Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of alpha4beta1 integrins.
|
J Biol Chem
|
2008
|
1.09
|
|
18
|
Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms.
|
Exp Cell Res
|
2008
|
1.09
|
|
19
|
Mesenchymal stem cell responses to bone-mimetic electrospun matrices composed of polycaprolactone, collagen I and nanoparticulate hydroxyapatite.
|
PLoS One
|
2011
|
1.05
|
|
20
|
Osteogenic differentiation of human mesenchymal stem cells directed by extracellular matrix-mimicking ligands in a biomimetic self-assembled peptide amphiphile nanomatrix.
|
Biomacromolecules
|
2009
|
1.04
|
|
21
|
Osteoblast adhesion and matrix mineralization on sol-gel-derived titanium oxide.
|
Biomaterials
|
2005
|
1.04
|
|
22
|
An in vitro regenerated functional human endothelium on a nanofibrous electrospun scaffold.
|
Biomaterials
|
2010
|
1.03
|
|
23
|
ST6Gal-I regulates macrophage apoptosis via α2-6 sialylation of the TNFR1 death receptor.
|
J Biol Chem
|
2011
|
0.99
|
|
24
|
Primary human marrow stromal cells and Saos-2 osteosarcoma cells use different mechanisms to adhere to hydroxylapatite.
|
J Biomed Mater Res A
|
2004
|
0.99
|
|
25
|
Low temperature induces the delivery of mature and immature CFTR to the plasma membrane.
|
Biochem Biophys Res Commun
|
2007
|
0.98
|
|
26
|
ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells.
|
J Ovarian Res
|
2013
|
0.95
|
|
27
|
Mesenchymal stem cell interaction with ultra-smooth nanostructured diamond for wear-resistant orthopaedic implants.
|
Biomaterials
|
2008
|
0.94
|
|
28
|
Delivery of platelet-derived growth factor as a chemotactic factor for mesenchymal stem cells by bone-mimetic electrospun scaffolds.
|
PLoS One
|
2012
|
0.94
|
|
29
|
Engineering an antiplatelet adhesion layer on an electrospun scaffold using porcine endothelial progenitor cells.
|
J Biomed Mater Res A
|
2011
|
0.92
|
|
30
|
Enhancement of peptide coupling to hydroxyapatite and implant osseointegration through collagen mimetic peptide modified with a polyglutamate domain.
|
Biomaterials
|
2010
|
0.91
|
|
31
|
Effect of altered glycosylation on the structure of the I-like domain of beta1 integrin: a molecular dynamics study.
|
Proteins
|
2008
|
0.91
|
|
32
|
Microporous dermal-like electrospun scaffolds promote accelerated skin regeneration.
|
Tissue Eng Part A
|
2014
|
0.87
|
|
33
|
Mesenchymal stem cell adhesion and spreading on microwave plasma-nitrided titanium alloy.
|
J Biomed Mater Res A
|
2006
|
0.86
|
|
34
|
Polyglutamate directed coupling of bioactive peptides for the delivery of osteoinductive signals on allograft bone.
|
Biomaterials
|
2012
|
0.85
|
|
35
|
Working group report: the roles of glycans in hemostasis, inflammation and vascular biology.
|
Glycobiology
|
2008
|
0.84
|
|
36
|
Mesenchymal stem cell adhesion and spreading on nanostructured biomaterials.
|
J Nanosci Nanotechnol
|
2004
|
0.82
|
|
37
|
Comparison of mesenchymal stem cell and osteosarcoma cell adhesion to hydroxyapatite.
|
J Mater Sci Mater Med
|
2008
|
0.81
|
|
38
|
Tunable delivery of bioactive peptides from hydroxyapatite biomaterials and allograft bone using variable-length polyglutamate domains.
|
J Biomed Mater Res A
|
2013
|
0.79
|
|
39
|
Comparing variable-length polyglutamate domains to anchor an osteoinductive collagen-mimetic peptide to diverse bone grafting materials.
|
Int J Oral Maxillofac Implants
|
2014
|
0.77
|
|
40
|
Enhanced Skin Regeneration Using a Novel Amniotic-derived Tissue Graft.
|
Wounds
|
2017
|
0.75
|